Hints and tips:
Related Special Reports
...The New York-based pharma group has acquired four companies — Arena, ReViral, Biohaven and Global Blood Therapeutics — that it expects will contribute about $10bn in revenues in 2030....
...Biotech business Redx Pharma this week blamed low liquidity on London’s junior market for its decision to delist its shares from Aim and re-register as a private company....
...But some investors believe selling discipline against a shot is a losing game when big pharma companies are competing to meet the demands of the one in eight people worldwide who are classed as obese....
...The first three sources are not the exclusive realm of knowledge industries such as tech or pharma....
...But trustbusters have fresh reasons to feel cross with the pharma industry. The US Federal Trade Commission now frowns on its “rampant consolidation”....
...It will acquire the rights to sell it in the US, where there is a $15bn market for IBD, and in Japan....
...Nippon Steel snapped up US Steel for $14.9bn last month. Astellas Pharma bought eye-treatment specialist Iveric Bio in a $5.9bn deal in May....
...Horizon had also attracted interest from French drugmaker Sanofi and US pharma group Johnson & Johnson....
...But pressure is mounting on pharma companies to switch to synthetic substances as populations decline for horseshoe crabs and seabirds that eat the creatures’ eggs....
...Some pharma companies disputed the annual cost figures published by the health department....
...Merck’s research chief has called on the UK government to make the country more welcoming to pharma companies, ahead of the US-based drugmaker breaking ground on a £1bn research centre in London next week...
...Healthcare spending accounts for about a fifth of US economic output. Competition authorities want to restrain its cost growth....
...Pao, speaking at the Financial Times US Pharma and Biotech Summit in New York, said he was confident the FTC would approve the Seagen deal....
...US....
...Regulators have taken notice after a study sparked fresh doubts over the usefulness of a Covid drug made by US pharma group Merck, raising questions about the costly procurement of antivirals during the...
...In a quieter deal environment, this deal underscores that Big Pharma has the means to make big bets....
...If you have the long pharma/short junk food pair trade on, email us: robert.armstrong@ft.com and ethan.wu@ft.com....
...Tokyo has argued that the measure was not targeted at China, but Beijing views it as in alignment with US steps to cut off China’s access to tools needed to manufacture advanced chips....
...Late on Friday, a New Jersey bankruptcy court ruled that the big pharma company could not pursue a bankruptcy deal with tens of thousands of consumers who claim its talc powder caused serious illness....
...OxyContin, a highly addictive drug, was promoted by Purdue Pharma as a non-addictive painkiller in the United States with unimaginably tragic consequences....
...Big pharma defends their patent strategies, arguing that intellectual property protection is required to justify continuing investment in existing drugs....
...In Amgen’s case, the FTC argued that the Big Pharma group could get buyers to favour Horizon’s drugs by bundling them with its own best medicines....
...“I’m glad the FTC is looking at this,” Schleifer told the Financial Times US pharma and biotech summit in New York....
...Astellas Pharma has agreed to buy US biotech group Iveric Bio for roughly $5.9bn, marking the Japanese drugmaker’s largest-ever acquisition and giving it access to the rapidly expanding market for age-related...
...Soriot’s record has made him a sought-after CEO within the pharma industry, where executives in the US are typically paid more....
International Edition